Results 111 to 120 of about 306 (158)
In vivo dissection of the mouse tyrosine catabolic pathway with CRISPR-Cas9 identifies modifier genes affecting hereditary tyrosinemia type 1. [PDF]
Rivest JF +10 more
europepmc +1 more source
The somatic FAH C.1061C>A change counteracts the frequent FAH c.1062+5G>A mutation and permits U1snRNA-based splicing correction. [PDF]
Scalet D +5 more
europepmc +1 more source
Engineering a transposon-associated TnpB-ωRNA system for efficient gene editing and phenotypic correction of a tyrosinaemia mouse model. [PDF]
Li Z +20 more
europepmc +1 more source
Progress in Gene Therapy for Hereditary Tyrosinemia Type 1. [PDF]
Thomas H, Carlisle RC.
europepmc +1 more source
A Case of Tyrosinemia Type III with Status Epilepticus and Mental Retardation.
Najafi R, Mostofizadeh N, Hashemipour M.
europepmc +1 more source
Analisi della struttura dei geni codificanti i recettori dell'ormone tiroideo in un modello di epatocancerogenesi sperimentale [PDF]
Pinna, Silvia
core +3 more sources
Some of the next articles are maybe not open access.
Related searches:
Related searches:
Acta Pathologica Japonica, 1979
A case of tyrosinemia in a three‐month‐old boy is presented. The patient appeared jaundiced initially with markedly elevated levels of serum tyrosine and a positive Millon‐reacting urine. Jaundice persisted and hepatospleno‐megaly gradually increased. He died due to liver failure on the 51st day after admission.
Y, Shinohara +5 more
openaire +2 more sources
A case of tyrosinemia in a three‐month‐old boy is presented. The patient appeared jaundiced initially with markedly elevated levels of serum tyrosine and a positive Millon‐reacting urine. Jaundice persisted and hepatospleno‐megaly gradually increased. He died due to liver failure on the 51st day after admission.
Y, Shinohara +5 more
openaire +2 more sources

